Literature DB >> 28842728

Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease.

S Herrera1, R Soriano1, X Nogués1, R Güerri-Fernandez1, D Grinberg2, N García-Giralt1, N Martínez-Gil2, S Castejón1, A González-Lizarán1, S Balcells2, A Diez-Perez3,4.   

Abstract

Camurati-Engelmann (CE) is a very rare disease affecting one in every million persons worldwide. It is characterized by an enlargement of long bones. We aimed to assess bone characteristics in three siblings with different tools. Even if there was an excess of bone density, quality seemed to be deteriorated.
INTRODUCTION: CE disease is a rare monogenic disorder affecting approximately one in every million persons worldwide. It is mainly characterized by a progressive hyperostosis of the periosteum and endosteum of the diaphysis of long bones. Limited data are available about bone characteristics in these patients. In three siblings with CE disease, we aimed to assess bone mineral density (BMD) and trabecular bone score (TBS) by dual-energy X-ray absorptiometry (DXA) and material characteristics at tissue level using bone impact reference point indentation.
METHODS: Clinical data were collected and a general laboratory workup was performed. At the lumbar spine and hip, BMD and TBS were measured using DXA imaging. Bone material strength index (BMSi) was measured by bone impact microindentation using an Osteoprobe instrument.
RESULTS: All three cases had densitometric values consistent with high bone mass (sum of Z-score at the lumbar spine and hip > 4). Hip BMD was extremely high in all three siblings at both total hip and femoral neck, while at the lumbar spine, two of them had normal values but the third again had very high BMD. TBS values were in the normal range. In contrast, BMSi measurements were at low or very low levels, compared with normal controls.
CONCLUSION: Despite strikingly increased BMD and normal microarchitecture, BMSi is affected in patients with CE. Microindentation could be an appropriate tool for assessing bone fragility in these patients. Bone disease in this group of patients requires further study to better understand the underlying regulatory mechanisms and their alterations.

Entities:  

Keywords:  Camurati-Engelmann; Microindentation; Progressive diaphyseal dysplasia; Rare bone disease

Mesh:

Year:  2017        PMID: 28842728     DOI: 10.1007/s00198-017-4198-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  18 in total

Review 1.  Molecular and radiological diagnosis of sclerosing bone dysplasias.

Authors:  W Van Hul; F Vanhoenacker; W Balemans; K Janssens; A M De Schepper
Journal:  Eur J Radiol       Date:  2001-12       Impact factor: 3.528

2.  Camurati-Engelmann disease: failure of response to bisphosphonates: report of two cases.

Authors:  Glaucio R W Castro; Simone Appenzeller; João Francisco Marques-Neto; Manoel B Bértolo; Adil M Samara; Ibsen Coimbra
Journal:  Clin Rheumatol       Date:  2005-01-20       Impact factor: 2.980

3.  Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease.

Authors:  Jonas Bondestam; Mervi K Mäyränpää; Shiro Ikegawa; Eino Marttinen; Heikki Kröger; Outi Mäkitie
Journal:  Clin Rheumatol       Date:  2007-01-06       Impact factor: 2.980

4.  Case for Diagnosis.

Authors:  E A Cockayne
Journal:  Proc R Soc Med       Date:  1920

5.  Biochemical markers of bone turnover in Camurati-Engelmann disease: a report on four cases in one family.

Authors:  M V Hernández; P Peris; N Guañabens; L Alvarez; A Monegal; F Pons; A Ponce; J Muñoz-Gómez
Journal:  Calcif Tissue Int       Date:  1997-07       Impact factor: 4.333

6.  Engelmann's disease of bone--a systemic disorder?

Authors:  A J Crisp; D P Brenton
Journal:  Ann Rheum Dis       Date:  1982-04       Impact factor: 19.103

7.  Progressive diaphyseal dysplasia: genetics and clinical and radiologic manifestations.

Authors:  Y Naveh; J K Kaftori; U Alon; J Ben-David; M Berant
Journal:  Pediatrics       Date:  1984-09       Impact factor: 7.124

8.  Misinterpretation of osteodensitometry with high bone density: BMD Z > or = + 2.5 is not "normal".

Authors:  Michael P Whyte
Journal:  J Clin Densitom       Date:  2005       Impact factor: 2.963

9.  Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.

Authors:  Michael P Whyte; William G Totty; Deborah V Novack; Xiafang Zhang; Deborah Wenkert; Steven Mumm
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

10.  Technical note: Recommendations for a standard procedure to assess cortical bone at the tissue-level in vivo using impact microindentation.

Authors:  A Diez-Perez; M L Bouxsein; E F Eriksen; S Khosla; J S Nyman; S Papapoulos; S Y Tang
Journal:  Bone Rep       Date:  2016-07-26
View more
  1 in total

1.  Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature.

Authors:  Manuela Schoeb; Neveen A T Hamdy; Frank Malgo; Elizabeth M Winter; Natasha M Appelman-Dijkstra
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-07       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.